Results 221 to 230 of about 90,488 (249)

CYP2D6 and tamoxifen: DNA matters in breast cancer

Nature Reviews Cancer, 2009
Lisa A Carey, Howard L Mcleod
exaly  

Tamoxifen

Reactions, 1984
openaire   +1 more source

Adjuvant tamoxifen and exemestane in early breast cancer (TEAM): a randomised phase 3 trial

Lancet, The, 2011
Hein Putter, Christos J Markopoulos, John M S Bartlett   +2 more
exaly  

Tamoxifen

Reactions Weekly, 1994
openaire   +1 more source

Anastrozole versus tamoxifen for the prevention of locoregional and contralateral breast cancer in postmenopausal women with locally excised ductal carcinoma in situ (IBIS-II DCIS): a double-blind, randomised controlled trial

Lancet, The, 2016
John F Forbes, Ivana Sestak, Anthony Howell   +2 more
exaly  

Aromatase Inhibitors as Adjuvant Therapy for Postmenopausal Patients With Early Stage Breast Cancer

Ca-A Cancer Journal for Clinicians, 2005
exaly  

Prednisone versus tamoxifen in patients with idiopathic retroperitoneal fibrosis: an open-label randomised controlled trial

Lancet, The, 2011
Augusto Vaglio, Federico Alberici, Umberto Maggiore   +2 more
exaly  

Adjuvant chemotherapy and timing of tamoxifen in postmenopausal patients with endocrine-responsive, node-positive breast cancer: a phase 3, open-label, randomised controlled trial

Lancet, The, 2009
C Kent Osborne
exaly  

Tamoxifen Infrequently Used by Women at Risk for Breast Cancer

Ca-A Cancer Journal for Clinicians, 2010
exaly  

A two-gene expression ratio predicts clinical outcome in breast cancer patients treated with tamoxifen

Cancer Cell, 2004
Dennis C Sgroi
exaly